Apr 16, 2021

GlaxoSmithKline hoping to deliver Australia’s next COVID treatment

GlaxoSmithKline hoping to deliver Australia’s next COVID treatment

Starpharma featured in The Sydney Morning Herald's daily COVID-19 update, as reported by Emma Koehn: ASX-listed companies have pivoted swiftly towards virus treatments and preventative in the past year, including Melbourne-based Starpharma which successfully brought a nasal spray to market in the UK last month. Read more here

 This contains certain forward-looking statements.